Dr. Shiovitz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4835 Van Nuys Blvd
Ste 104
Sherman Oaks, CA 91403Phone+1 310-285-9421Fax+1 818-986-9716
Education & Training
- Cedars-Sinai Medical CenterResidency, Psychiatry, 1986 - 1987
- Cedars-Sinai Medical CenterResidency, Psychiatry, 1984 - 1985
- VA Greater Los Angeles Healthcare SystemInternship, Transitional Year, 1983 - 1984
- University of Michigan Medical SchoolClass of 1983
Certifications & Licensure
- CA State Medical License 1984 - 2026
- GA State Medical License 1995 - 2007
- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo Start of enrollment: 2013 Jul 01
- A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease Start of enrollment: 2016 Jun 01
Publications & Presentations
PubMed
- 1 citationsThe Patient in Your Alzheimer’s Disease Study May be in Another: Duplication and Deception in Clinical Trials of Alzheimer’s DiseaseThomas Shiovitz, B. Steinmiller, C. Steinmetz, S. Perez, R. Oseas
The Journal of Prevention of Alzheimer's Disease. 2020-01-01 - 66 citationsMitigating the Effects of Nonadherence in Clinical TrialsThomas M. Shiovitz, Earle Bain, David J. McCann, Phil Skolnick, Thomas P. Laughren
Journal of Clinical Pharmacology. 2016-09-01 - 165 citationsTargeting Prodromal Alzheimer Disease With Avagacestat: A Randomized Clinical TrialVladimir Coric, Stephen Salloway, Christopher H. van Dyck, Bruno Dubois, Niels Andreasen
JAMA Neurology. 2015-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: